Feature | July 19, 2013

Mount Sinai Medical Center First in New York to Offer HeartMate II Pocket Controller

July 19, 2013 — The Mount Sinai Medical Center is the first medical center in New York City to offer the HeartMate II pocket controller, newly approved by the U.S. Food and Drug Administration (FDA), to help its advanced heart failure patients maintain more active lifestyles. This latest-generation controller for the HeartMate II left ventricular assist device (LVAD) is a new small, lightweight, patient-friendly external controller about the size of a smart phone that easily fits in a patient’s front pocket and powers their heart to pump.

“This new HeartMate II controller is a good step forward for our heart failure patients who are awaiting a heart transplant or in need of long-term, permanent support for their survival,” says Sean P. Pinney, M.D., director of the Advanced Heart Failure & Cardiac Transplantation Program at Mount Sinai. “With its smaller size and intuitive safety features, we expect the new controller will enhance the daily lives of our heart failure patients.”

Mount Sinai has one of the largest LVAD programs in the United States, with its cardiothoracic surgeons implanting approximately 50 each year. The center started using LVAD technology in 2006 for advanced heart failure patients. It is used as a bridge-to-transplant (BTT) therapy or destination therapy (DT) for permanent support. In addition, Mount Sinai performs dozens of successful heart transplants each year.

“This new controller will improve the LVAD patient’s overall experience [and] heighten the quality of their life by supporting their active lifestyle, while providing pocket-sized peace of mind for them and their clinical care team,” says Kimberly Ashley, FNP-BC, the VAD program manager for the Advanced Heart Failure & Cardiac Transplantation Program. “We hope to expand the use of this pocket-sized HeartMate II controller to not only new patients but also those current HeartMate II users to give them the option to swap out their old controller for the smaller, safer version, making their lives more comfortable and normal during their daily activities.”

The new patient-friendly controller is a small computer attached to the HeartMate II LVAD via one side cable. It enhances patients’ safety by powering their LVAD to pump their heart, monitoring their vital signs and alerting them of any concerns. Its new design features a diagnostic check system to make sure device wires are intact and functional, special visual alarms, precise onscreen instructions for the patient and longer backup battery power. In addition, the device is programmed with 37 languages to serve diverse patient populations.

“We do extensive patient education training before and after LVAD surgery to teach patients exactly how their controllers work, how to closely monitor their LVAD’s status and also to be vitally aware of any issues or concerns that may arise,” says Bess Griffin, RN, BSN, the VAD coordinator for the Advanced Heart Failure & Cardiac Transplantation Program. “The staff — who have begun training on the new, smart, smaller controller — really enjoy the device’s very easy, user-friendly interface. Thanks to the new controller we are expecting patients may be trained more quickly and feel more confident in caring for their device at home.”

The pocket controller is available for new advanced heart failure patients in need who receive HeartMate II, as well as for current HeartMate II patients who wish to upgrade their existing system controllers.

For more information: www.mountsinai.org

Related Content

News | Heart Failure| October 02, 2015
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the...
Johns Hopkins, sticky gel, stem cells, rat hearts, heart attacks

Hydrogel applied to beating rat hearts improves stem cell uptake by the heart muscle and speeds up tissue healing after heart attack. Image courtesy of Johns Hopkins Medicine.

News | Stem Cell Therapies| September 29, 2015
A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and...
American Heart Association, AHA, heart failure, HF, Rise Above Heart Failure initiative, report
News | Heart Failure| September 29, 2015
September 29, 2015 — A new report from the American Heart Association (AHA) projects that the number of Americans dia
Zoll, acquires, Kyma Medical Technologies, LifeVest, µ-Cor System, heart failure, remote monitoring

µ-Cor System image courtesy of Kyma Medical Technologies

News | Remote Monitoring| September 21, 2015
Zoll Medical Corp. announced that it has acquired Tel Aviv, Israel-based Kyma Medical Technologies Ltd., which develops...
Freedom Driver, SynCardia, recall, Total Artificial Heart, TAH-t, part failure

Freedom Driver attached to Total Artificial Heart. Image courtesy of SynCardia.

News | Ventricular Assist Devices (VAD)| September 18, 2015
SynCardia Systems initiated a Class I recall of the Freedom Driver Systems used with the company’s temporary Total...
ICER, CardioMEMS, Entresto, congestive heart failure, cost-effectiveness

CardioMEMS image courtesy of St. Jude Medical.

News | Heart Failure| September 16, 2015
The Institute for Clinical and Economic Review (ICER) has released a new report offering a comprehensive review of...
Thoratec, HeartMate II LVAS, Urgent Device Correction Letter, Pocket System Controller, backup battery
News | Ventricular Assist Devices (VAD)| September 16, 2015
Thoratec Corp. issued a voluntary Urgent Medical Device Correction Letter to all hospitals who have patients supported...
Michigan, See You in 7, heart failure, readmissions, ACC
News | Patient Engagement| September 15, 2015
Michigan hospitals participating in the American College of Cardiology’s “See You in 7” program demonstrated important...
sleep apnea, pulse oximetery, congestive heart failure, CHF, pulse-oximetry, Thomas Jefferson University
News | Patient Monitors| September 09, 2015
Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring...
Sunshine Heart, C-Pulse, COUNTER HF, FDA, protocol amendment, mortality

C-Pulse System image courtesy of Sunshine Heart

News | Heart Failure| September 08, 2015
Sunshine Heart Inc. announced the U.S. Food and Drug Administration (FDA) has approved an amendment to the stopping...
Overlay Init